최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Best practice & research. Clinical haematology, v.32 no.4, 2019년, pp.101097 -
Cooper, Mathew L. (Corresponding author.) , DiPersio, John F.
Abstract At present, the only curative therapy for patients with T-cell malignancies is allogeneic stem cell transplant, which has associated risks and toxicities. Novel agents have been tried in relapsed T-cell acute lymphoblastic leukemia (T-ALL), but only one, with 20%–30% complete remissi...
Int J Clin Oncol Ma 22 18 2017 10.1007/s10147-016-1045-2 T-cell lymphomas, a challenging disease: types, treatments, and future
Genes Chromosomes Cancer Karrman 56 89 2017 10.1002/gcc.22416 Pediatric T-cell acute lymphoblastic leukemia
Blood Marks 114 5136 2009 10.1182/blood-2009-08-231217 T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993)
J Clin Oncol Goldberg 21 3616 2003 10.1200/JCO.2003.10.116 Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience
Blood Litzow 126 833 2015 10.1182/blood-2014-10-551895 How I treat T-cell acute lymphoblastic leukemia in adults
Sci Transl Med Porter 7 2015 10.1126/scitranslmed.aac5415 Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
J Clin Oncol Kochenderfer 33 540 2015 10.1200/JCO.2014.56.2025 Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor
Blood Park 127 3312 2016 10.1182/blood-2016-02-629063 CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date
Haematologica Chiaretti 94 160 2009 10.3324/haematol.2008.004150 T-cell acute lymphoblastic leukemia
Biol Blood Marrow Transplant Burke 21 2154 2015 10.1016/j.bbmt.2015.08.023 Transplant outcomes for children with T cell acute lymphoblastic leukemia in second remission: a report from the Center for International Blood and Marrow Transplant Research
Eur J Haematol Thota 98 425 2017 10.1111/ejh.12862 Inotuzumab ozogamicin in relapsed B-cell acute lymphoblastic leukemia
N Engl J Med Kantarjian 376 836 2017 10.1056/NEJMoa1609783 Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia
Blood Dores 119 34 2012 10.1182/blood-2011-04-347872 Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007
Nat Rev Drug Discov Andersson 13 357 2014 10.1038/nrd4252 Therapeutic modulation of Notch signalling--are we there yet?
Clin Cancer Res Carroll 23 873 2017 10.1158/1078-0432.CCR-16-2825 Beating the clock in T-cell acute lymphoblastic leukemia
J Immunol Methods Campana 243 59 2000 10.1016/S0022-1759(00)00228-3 Immunophenotyping of leukemia
Am J Clin Pathol Khalidi 111 467 1999 10.1093/ajcp/111.4.467 Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases
Br J Haematol Patel 159 454 2012 10.1111/bjh.12042 The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report
Blood Milush 114 4823 2009 10.1182/blood-2009-04-216374 Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4
Leukemia Cooper 32 1970 2018 10.1038/s41375-018-0065-5 An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
Mol Ther Osborn 24 570 2016 10.1038/mt.2015.197 Evaluation of TCR gene editing achieved by TALENs, CRISPR/Cas9, and megaTAL nucleases
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.